Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Is drug–placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?

Journal of Affective Disorders(2008)10.1016/j.jad.2008.01.020Source: DataRank Database

Is drug–placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed? is a research paper published in Journal of Affective Disorders (2008). On theSindex it has a DataRank of 1.3. It has been cited 15 times, with 13 citing works in its 1-hop citation network.

N/A

1.3DataRank · unranked

Scored on demand from live citation data

15 citations · 13 citing works in its network

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 2.41)OA: closedTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 32%Citation Network 68%

Base Score Contribution

0.416

From this paper's citation signal

Citation Network Contribution

0.883

From 8 citing papers with measurable signal

Learn more about DataRank methodology →

Authors (2)

Xénia Gonda,Zoltán Rihmer

Live enrichment

PubMed:18280581 OpenAlex:https://openalex.org/W2035815644

FWCI

2.41

Citation Percentile

0.9%

Citation Trend

2012

2013

2015

2016

2017

2021

closedLicense: https://www.elsevier.com/tdm/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0165032708000566?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0165032708000566?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jad.2008.01.020

repositoryhttps://pubmed.ncbi.nlm.nih.gov/18280581

Fields of Study

Treatment of Major DepressionPain Management and Placebo EffectMental Health Research TopicsAntidepressive AgentsMajor Depressive DisorderHumansPlacebo EffectRandomized Controlled Trials as TopicTime Factors

MeSH Terms

Antidepressive AgentsMajor Depressive DisorderDepressive Disorder, MajorHumansTime FactorsPlacebo EffectRandomized Controlled Trials as Topic

Keywords

AntidepressantDrugPlaceboDepression (economics)Drug trialPlacebo responseMedicinePsychiatryTerm (time)PsychologyClinical trialInternal medicineAnxietyAlternative medicine

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (1)

Novel approaches to drug-placebo difference calculation: evidence from short-term antidepressant drug-trials

N/A

0.248DataRank · unranked

Human Psychopharmacology: Clinical and Experimental(2011)

co-cited

10.1002/hup.1206

Is drug–placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?

FAIR Checklist

DataRank Breakdown

Authors (2)

Impact

Open Access

Topics

Related Papers (1)